Abstract
Identification of epistasis affecting complex human traits has been challenging.
Focusing on known coronary artery disease (CAD) risk loci, we explore pairwise statistical interactions between 8,068 SNPs from ten CAD genome-wide association studies (n=30,180). We discovered rs1800769 and rs9458001 in the vicinity of the LPA locus to interact in modulating CAD risk (P=1.75×10 -13 ). Specific genotypes (e.g., rs1800769 CT) displayed either significantly decreased or increased risk for CAD in the context of genotypes of the respective other SNP (e.g., rs9458001 GG vs. AA). In the UK Biobank (n=450,112) significant interaction of this SNP pair was replicated for CAD (P=3.09×10 -22 ), and was also found for aortic valve stenosis (P=6.95×10 -7 ) and peripheral arterial disease (P=2.32×10 -4 ). Identical interaction patterns affected circulating lipoprotein(a) (n=5,953; P=8.7×10 -32 ) and hepatic apolipoprotein(a) (apo(a)) expression (n=522, P=2.6×10 -11 ). We further interrogated potential biological implications of the variants and propose a mechanism explaining epistasis that ultimately may translate to substantial cardiovascular risks.
Main text
Globally, coronary artery disease (CAD) is the largest contributor to morbidity and mortality 1 . Genetic understanding of CAD has benefited from recent genome-wide association studies (GWAS), which have identified multiple variants to independently and additively propagate CAD susceptibility 2 . Less attention has been paid to epistasis in which variants act non-additively or, paradoxically, are dependent on the genetic context 3, 4 . Albeit epistasis has broadly been shown to affect multiple traits in fruit flies 5 , mice 6 , and humans 7 , examples demonstrating biological relevance for epistasis via statistical approaches have only been investigated in model organisms [8] [9] [10] . Earlier attempts were largely unsuccessful given the computational challenges such as the curse of dimensionality, model complexity and bias from linkage disequilibrium (LD).
Moreover, such efforts often lacked successful replication and/or biological interpretations of the statistical interactions [11] [12] [13] [14] [15] . Here, we aimed to statistically identify pairwise SNP interactions in the context of CAD and explored how biological epistasis may functionally contribute to disease susceptibility.
We started from the search space of 56 broad-sense CAD susceptibility regions defined as ±500kb flanking regions of known CAD risk loci reported from previous CAD GWAS 16 (Methods all pairwise SNPs (nSNP_LDpruned=8,068) along a two-step scheme as detailed in the Methods and in Supplementary Fig 1. As a result, four SNP-pairs (Methods, Supplementary Table 2 , Supplementary Fig 2) , displaying consistent (in at least eight of ten studies) and significant (P ≤ 4.618×10 -9 ) effects met our statistical criteria for candidate epistasis (Methods, Supplementary Fig 3, 4) . The top SNP-pair (rs1800769- To facilitate comprehension, we investigated the relative odds ratio for subgroups of individuals with all nine possible genotype combinations. As a result, opposing genetic effects were observed for rs1800769, in that increasing dosage of T-alleles
) went along with lower CAD risk in rs9458001 [G] homozygote individuals, but with higher risk in rs9458001[A] homozygotes (Fig 2a) .
Comparable effects were observed but vice versa for rs9458001 given the different genetic context of rs1800769 (Fig 2a) .
The few double homozygote [T/T] -[A/A]
genotype carriers were all found amongst CAD cases (Supplementary Note III). We further dissected the genetic context into four possible allele-specific subgroups of haplotype samples (Methods, Supplementary Fig 6) . The allele combination [T-A] (~3% in the population) displayed an odds ratio for CAD (1.84; Fig 2b) , which was higher than that of any other common risk alleles at the Lp(a) locus, including rs10455872 at the Lp(a) locus 2, 16 ( Supplementary Fig 7) . Table 6 ). Again, given the context of one SNP, paradoxical effects were observed for the other SNP (Fig 3, Supplementary Fig 8) Supplementary Fig 8) . This suggests that differential gene expression activity underlies a large component of the statistical interaction related to the two SNPs.
Finally, we wish to propose a hypothetical molecular mechanism of epistasis in that the expression activity of the LPA gene is determined by the two SNPs coregulating the enhancer-promoter interaction ( Supplementary Fig 10) . On the one hand, Table 11 ), which in turn changes the CTCFcohesin topological structure ( Supplementary Fig 10) . Combinatorially, the two SNPs may form context-dependent promoter-enhancer interactions in four scenarios that finally lead to differential gene expressions on a large magnitude ( Supplementary Fig   10) . A note of caution needs to be added, however, since the discussed SNP-SNP interaction is just one of many possible interactions as there are other SNPs at the locus that are in LD with the ones that we discovered.
An inherent challenge in testing for epistasis of nearby SNPs, even if they are in very low LD, is to discriminate interacting SNPs from SNPs representing a specific haplotype. In our case, it seems that the profound biological effects of the interacting pair were amplified in that the genotype combination leading to the highest transcriptional activity is found on a haplotype that contains a low number of KIV-2 CNV repeats, which by independent mechanisms may lead to higher Lp(a) serum levels.
However, Lp(a) serum concentrations adjusted for the KIV-2 CNV and apo(a) expression levels were both strongly affected by the interacting SNP pair, which strongly argues -when taken together with other genetic and molecular data (Supplementary Note VI) -for a true epistatic effect.
In summary, we have identified for the first time a SNP-pair at the LPA locus that epistatically affects CAD susceptibility via large-scale statistical interaction analyses.
Consistent effects were validated in multiple cohorts, across different cardiovascular traits and intermediary risk factors and traced all the way to apo(a) expression in the liver. The data reemphasize profound biological effects of massively elevated Lp(a) levels in increasing cardiovascular risks. We propose a hypothetical mechanism underlying epistasis of the two SNPs in coordinating gene regulation, and call for further research of epistasis in complex disease. Numbers of pseudo samples were given corresponding to the subgroups of haplotypes (allele combinations). 
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UK Biobank
The UK Biobank project (http://www.ukbiobank.ac.uk) is a large prospective cohort study of ~500,000 individuals from across the United Kingdom, aged 40-69 years at recruitment 41 . Following informed consent, a rich variety of phenotypic and healthrelated information was collected for each participant, making the resource unprecedented in its size and scope. In addition to self-reported information, including basic demographic data, dietary and exercise habits, multiple physical, cognitive and biochemical measurements were obtained. However, biochemical data for each of the four main blood lipids were not available at the time of analyses. UK Biobank participants are being followed up through electronically linked health-related records.
Health-related outcome records include death notifications and cancer diagnoses through linkage to national death and cancer registries, and hospital inpatient episode statistics, which contain coded data on admissions, operations and procedures (primary and secondary). In this study, CAD cases were defined using the "HARD" criteria 2 as individuals with fatal or nonfatal myocardial infarction (MI), percutaneous transluminal coronary angioplasty (PTCA) or coronary artery bypass grafting (CABG).
Peripheral arterial disease (PAD) cases were defined as self-reported history of PAD or leg claudication/ intermittent claudication, or hospitalization or death due to ICD9-443.9, 444, ICD10-I73.9,I74. Aortic valve stenosis cases were defined as self-reported history of aortic stenosis, or hospitalization or death due to ICD9-424.1, ICD10-I35.0.
KORA F3/F4 studies
Individual-level genotypes were obtained from Augsburg population studies from 
STARNET Study
RNAseq have been generated from liver in a total of 522 CABG CAD patients from the Stockholm-Tartu Reverse Network Engineering Task (STARNET) study 44 . All patients were Caucasian (30% females), 27% had diabetes, 77% had hypertension, 68% had hyperlipidemia, and 37% had a myocardial infarction before age 60. 44 .
Broad-sense CAD susceptibility regions
We focused our analysis on loci with previous evidence of genome-wide association with CAD in order to restrict the number of variants for testing of statistical epistasis with the aim to enhance speed and the likelihood of positive finding. We collected the lead SNPs from the 56 published CAD susceptibility loci 16, 22 , and decided on ±500kb as a balanced threshold for the flanking range surrounding the known loci (i.e. the broad-sense CAD susceptibility regions), which could meanwhile maximize the heritability covered by the regions and minimize the computational burden. Indeed, variance explained by the lead SNPs only achieved 46% proportion to that could be explained by including their flanking ±500kb regions together (Supplementary Note I).
Altogether there are 8,068 SNPs with pairwise r 2 < 0.5 located in the broad-sense CAD susceptibility regions.
Statistical interaction analysis for CAD
We used the general framework of detecting statistical epistasis in quantitative genetics as proposed by Hansen and Wagner 46 , and as a pilot study focused specifically on the pairwise epistasis between two loci (SNPs). Formally (Eq. (1) and bint for the interaction effect (epistasis coefficient) of the coded variables (snp1 and snp2). In this way, the epistasis coefficient bint indicates the directionality and quantifies the strength of the effect between both loci (snp1 and snp2).
(1)
We started exploration of statistical epistasis with all available SNPs located in the broad-sense CAD susceptibility regions across the genome but with LD redundancy pruned to pairwise r 2 < 0.5 (nSNP_LDpruned =8,068). The statistical interaction calculations were done on this set of SNPs with a low LD structure, with I -primary filtering of potential candidates, and II -screening and final confirmation ( Supplementary Fig 1) .
Step I aimed the fast speed identification of potential significant interaction terms, as well as their respective genotype models, with the assistance of GLIDE GPU computation tool 47 . In total a set of nSNP_all =7,579 variants spanning across the complete block, were further investigated for fine-mapping using logistic regression, performed in R (ntests_of_given_model = nSNP_all × (nSNP_all -1) / 2 = 28,716,831). Here variants were encoded in the most significant genetic models resulting from
Step I, and the equation was extended (Eq. (2)) to correct for population stratification and employing a logistic model for the dependent variable. Population
structures for each cohort were captured in the genotyped data with multidimensional scaling (MDS) analysis of the identity-by-state (IBS) matrix, computed via PLINK 48 (v1.90b3.42).
In the discovery phase, the same epistasis testing was performed based on 1000G
imputed genotypes in each of the ten CAD case-control studies separately with the adjustment of top 10 MDS components, and then fixed-effect meta-analysis to estimate the overall effect size and standard error. The final epistasis pair of interest was then reanalyzed in the same study with HRC imputation to enable a more complete coverage Firstly, we picked up SNP pairs that were highly replicated, as previous statistical epistasis explorations have been frequently blamed for low replication 3, 49 . Here we retained only SNP-pairs, which displayed statistical epistasis both significantly and consistently in at least 8 studies (out of 10) in the discovery data, based on both v1000G
and vHRC imputation.
Secondly, when our statistical interaction SNP pairs were located on the same chromosome (i.e., cis-epistasis), we clarified the regional LD structure to confirm the independence of LD between two target SNPs (snp1 and snp2). We filtered out all pairs with LD r 2 > 0.2 between snp1 and snp2 (inter-pair criteria). Moreover, we assumed that if significant and true statistical epistasis effect exists between snp1 and snp2, then at least weak interaction signals should be detectable between all extended SNPs in high LD with each of the two interacting SNPs (respectively all proxies of snp1 and all proxies of snp2), unless either SNP itself is a LD singleton and has limited or no other variants nearby linked with it. Therefore, to maximize the replication of the true positive discovery, we focused on those pairs with both target SNPs as non-LD-singleton. All singletons or SNPs with low LD (r 2 between 0.2 -0.5 with any other variants) were not further considered. All SNPs in LD r 2 > 0.5 were grouped into the same target SNP group ( Supplementary Fig 2a) as snp1 group or snp2 group (intra-pair criteria), and the SNP pair with the largest effect size for the interaction coefficient was taken as the lead pair (Supplementary Table 3) .
Thirdly, to test the independence of the statistical epistasis effect against the effect from a third SNP in the vicinity of snp1 or snp2, or from any known CAD susceptibility loci reported via traditional GWAS approach, conditional analyses were performed in all ten studies followed by meta-analysis. Dosage model was assigned to the third SNP (snp3), extracting from the latest compiled list of 164 known CAD GWAS SNPs 50 , and from all available SNPs in the ±200kb flanking regions of snp1 and snp2. Logistic regression was utilized to estimate the effect of the bint (epistasis coefficient) but with snp3 as an additional covariate (Eq. (3)).
As a result, four pairs displaying consistent effects in at least 8 studies, hit all the defined criteria for statistical epistasis (Supplementary Table 2) , with the top pair as two SNPs rs1800769 and rs9458001 on chromosome 6 in dosage-dosage model. The effect sizes were consistent across all studies, except for GerMIFSI due to the unavailability of one of the SNPs (or any proxy) in the pair based on 1000G imputation, but proxies (r 2 ≥ 0.98) were available in our data based on HRC imputation and showed consistently strong interactions across all ten studies ( Supplementary Fig 3) . With the aim to statistical-to-biological translation, we annotated the genetic locations of the 8 SNPs in these four candidate pairs (Supplementary Table 2 ), and found one of the pairs with both SNPs located nearest to a known CAD risk gene -LPA, i.e., the pair of rs1800769 and rs9458001, with the former at the LPA promoter and the latter at the upstream intergenic region. We thereafter focused on this top epistasis SNP pair with the highest potential to be biologically relevant for further biological and functional analyses, and argue against cis-epistasis being a pure statistical artifact 51 . 
Statistical interaction analysis on intermediate factors
For a sample of 2,831 LURIC individuals, a series of cardiovascular related risk factors were also measured including circulating Lp(a) concentration, in addition to the records of CAD status. Lp(a) was measured in EDTA plasma in the scale of mg/dl.
Logistic regression was performed for CAD status, with (Eq. (6)) and without (Eq. (5)) adjustment for the inverse normal transformation Lp(a) to estimate the effect change for the epistasis coefficient bint
For the epistasis effect on the apo(a) expression activity we applied two approximate measurements: a) the effect on the hepatic LPA-mRNA expression by RNA-seq from STARNET 44 Study (Eq. (7)); and b) the effect on the total Lp(a) level adjusted by the effect related due to KIV-2 CNV (Eq. (8), Supplementary Note IV).
Lp(a) concentration was inverse normal transformed. Analysis was first performed in KORA F3 and F4 separately. Then meta-analysis was performed to estimate the effects and significance.
lpa ~ b0 + b1×snp1 + b2×snp2 + bint×snp1× snp2 + bKIV×isoform (8)
Relative effect size analysis for genotypes and haplotypes.
The effect of interaction term bint indicates the deviation of the observed effect compared to the expected combination of effect given the respective effect-allele models of the two SNPs, but does not tell the actual risk difference among subgroups of individuals divided according to the interactive SNP-pair. In order to characterize the manifestation of interaction as to how the genetic effect of one SNP is mutually dependent on the genetic context of the other SNP, we dissected the genetic effect of epistasis by analyzing the effect of two SNPs from two perspectives: in genotypes (e.g., biallelicwise in 3 * 3 = 9 genotype combinations), and in haplotypes (e.g., monoallelic-wise in 2 * 2 = 4 haplotype) ( Supplementary Fig 6) . For genotypes, we set the effect for the majority group as the baseline for comparison, and performed multivariate regression with 9 genotype combination categories, to estimate the relative effect change of each group on multiple levels (Eq. (9)), including CAD odds ratio, total Lp(a) level, LPA mRNA expression in liver, and isoform-independent Lp(a) level, based on the corresponding data.
Indeed, monoallelic-wise haplotype would be more direct reflection of the genetic context. Given that only genotypes, rather than haplotypes, are directly measured and observed in genotyping arrays, we inferred estimated haplotypes via linkage phasing of the SNP genotypes for ambiguous (heterozygous at both SNPs) haplotypes using R package hapassoc. Firstly, using the genotype data an input a list of possible haplotypes that are compatible with each person's genotype from the pre-processing function "pre.hapassoc", which generates dummy samples for uncertain haplotypes, additionally generated with probabilities. Then the haplotype association analyses implemented in the "hapassoc" function were conducted based on generalized linear models using the expectation-maximization (EM) algorithm. Similarly, we set the effect for the majority group as the baseline for comparison, and performed multivariate regression with 4 haplotype categories, to determine the relative effect change of each group on multiple levels (Eq. (10)). 
Methylation QTL analysis
We utilized the resource published by Gaunt et al 37 Table 11 ). Furthermore, we analyzed methylation array data from a subsample of 588 LURIC participants (Illumina EPIC array) measured in blood cells. Raw data were processed following the recommendations from the CKDGen consortium. There were 487 overlapping samples with both genotype and methylation data available that underwent filtering for quality control. All 565 methylation probes in the LPA flanking region (chr6:160363532-161643608, hg19) were extracted. Genotype-methylation associations were performed for rs1800769 and rs9458001, and all non-SNP-overlapping methylation probes (SNPprobe distance >1bp) with p < 0.01 to either SNP were checked. Only rs9458001 was significantly associated with CpG methylation levels, and was reported (Supplementary Table 11 ). The rs9458001[A] allele was associated with reduced methylation of a CpG island in the region between the two SNPs (~15kb upstream of rs1800769 and downstream of rs9458001), which was consistent based on the above two independent methylation array analyses.
Functional annotation
Annovar 52 was utilized to annotate the genomic location, location relative to the nearby gene, and putative regulatory functions. Haploreg4.1 53 was utilized to annotate the genomic position, LD structure in the European population, and ENCODE 52 annotation were integrated to capture possible regulatory elements of promoter, enhancer, and transcriptional factor binding motifs (Supplementary Table 10 ).
